Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Heart FailureCardiac FailureHeart DecompensationCongestive Heart Failure(CHF)Myocardial Failure
Interventions
BEHAVIORAL

Social prescribing

The intervention consists of SP, wherein patients identified as having significant SDOH-related vulnerabilities on the SPARK questionnaire or during an interview will have a consultation with a LW who will provide them with social prescriptions. LWs are individuals who LINK individuals with social needs to existing community supports and services within the community

Trial Locations (1)

H4A 3J1

Research Institute of the McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT06628973 - Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure | Biotech Hunter | Biotech Hunter